Related Experiment Video
Updated: May 29, 2026
05:47
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Structural alerts for predicting clastogenic activity of pro-oxidant flavonoid compounds: quantitative
Estela Guardado Yordi1, Enrique Molina Pérez, Maria Joao Matos
1Department of Food Science and Technology, Faculty of Chemistry, University of Camaguey, Camaguey, Cuba. estela.guardado@reduc.edu.cu
Journal of Biomolecular Screening
|September 24, 2011
Summary
Researchers identified key structural features of pro-oxidant flavonoids linked to clastogenic activity. This finding aids in designing safer, potentially bioactive flavonoids for nutraceuticals and functional foods.
Area of Science:
- Medicinal Chemistry
- Computational Toxicology
Background:
- Flavonoids exhibit diverse biological effects, including pro-oxidant activity at high concentrations.
- Understanding the structural basis of flavonoid toxicity is crucial for their safe application.
Purpose of the Study:
- To identify structural alerts associated with the clastogenic (DNA-damaging) activity of pro-oxidant flavonoids.
- To develop a predictive model for clastogenicity based on flavonoid structure.
Main Methods:
- Quantitative structure-activity relationship (QSAR) study using the topological substructural molecular design (TOPS-MODE) approach.
- Development of a virtual screening method for clastogenic activity.
- Analysis of molecular bond matrices considering hydrophobic, electronic, and steric features.
Main Results:
- Established structural criteria for maximal clastogenicity in pro-oxidant flavonoids.
- Key features include specific hydroxyl, carbonyl, methoxyl, and phenyl group placements, and the absence of a 2,3-double bond in ring C.
- Identified specific hydroxyl groups at positions 5 and 7 in ring A.
Conclusions:
- The developed clastogenic model can be used for screening novel pro-oxidant compounds.
- This structural alert facilitates the design of safer flavonoids for use in nutraceuticals and functional foods.
- Potential for developing new bioactive flavonoids with enhanced safety profiles.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...